As the rates of autism spectrum disorder (ASD) continue rising in the United States and around the world, so does the market for treating the immune and brain dysfunction associated with the neurological and developmental disorder that affects one in 36 eight-year-old children in the U.S., with one in six suffering with a developmental disability. The global market for ASD treatment, currently estimated to be worth about $7.5 billion by market research firm Fortune Business Insights of Pune, India, is projected to more than double by 2030 to just over $13 billion. The market is broken down by three segments: autistic disorder, Asperger’s syndrome, and Pervasive Developmental Disorder (PDD).1 2 3
Note that these estimates are extremely conservative compared to those provided by Allied Market Research of Portland, Oregon, which peg the ASD treatment market at closer to $30 billion today and forecast it may grow to $43.2 billion by 2031. Some market researchers speculate this market could be a “next industry giant.”1 4
According to Fortune Business Insights:
An increase in the prevalence of autism spectrum disorder (ASD) is positively impacting the growth of the market globally, which has led to increasing demand for clinical research for effective treatment.5
This prevalence rate, combined with the high unmet patient population in emerging countries, is anticipated to surge the demand for novel and effective drugs and therapies for autism spectrum disorder treatment. Consequently, this surge in demand is expected to drive the market growth.3
In both the forecasts by Fortune Business Insights and Allied Market Research, North America is expected to dominate the ASD treatment market because of increases in “product launches” in the region, a mature “health care infrastructure” and presence of “key players.” In 2022, North America accounted for about 59 percent of the share of the market.3 4
Then, of course, there is simply a higher demand in North America for treatment and other services, given that there is a significantly higher rate of autism in the United States compared to many other countries. While the World Health Organization (WHO) estimates that the average rate of autism in the world is one in 100 children, in the U.S. it is one in 36 and climbing.6 7 8
Both forecasts list the following companies as the top 10 providers of ASD treatments over the next decade:
– AbbVie, Inc. of Chicago, Illinois
– Axial Therapeutics, Inc. of Woburn, Massachusetts
– Bristol-Myers Squibb Co. of Princeton, New Jersey
– Cognoa, Inc. of Palo Alto, California
– Curemark LLC of Rye, New York
– dfusion, Inc. of Scotts Valley, California
– EarliTec Diagnostics, Inc. of Decatur, Georgia
– Jazz Pharmaceuticals plc of Ireland
– Johnson & Johnson, Inc. of New Brunswick, New Jersey
– Novartis AG of Basel, Switzerland
Communications and behavioral therapies appear to be the best available treatments for ASD. These include:
– Integration of mobile apps, virtual reality, and other digital tools into ASD treatment plans for enhanced accessibility and engagement.
– Increasing adoption of telehealth services for remote consultations and therapy sessions, improving access to specialists and reducing geographical barriers.
– Growing emphasis on empowering parents and caregivers with evidence-based strategies to support their children’s development and manage challenging behaviors.
– Therapies aimed at enhancing daily living skills, social integration, and communication beyond symptom management are gaining traction.1 3
Several biopharmaceutical companies have been working to develop drug therapies such as stimulants (like Ritalin and Concerta), selective serotonin reuptake inhibitors (SSRIs), antipsychotics (like Aripiprazole and Risperidone), and sleep medications. The available drug therapies can reportedly reduce the frequency and intensity of repetitive behaviors; decrease anxiety, irritability, tantrums and aggressive behaviors and improve eye contact.2 3 9 10
But all of these drug therapies have side effects. SSRIs, for example, have been linked to an increased risk of suicidal thoughts. Stimulants may cause lower appetite, increased repetitive movements, stomach ache, headaches, dizziness, sleep disturbance and tendencies to withdrawal from family and other people. Antipsychotic drugs may cause increased appetite, weight gain, tiredness or drowsiness, drooling, increased heart rate and stiff arms and legs or uncontrollable jerky movements.10 11
In 2018, the U.S. Food and Drug Administration (FDA), granted a breakthrough therapy designation for an ASD treatment drug called Balovaptan, developed by Swiss pharmaceutical company Roche AG. The designation opened the door for accelerating development and approval of the drug. After completing Phase 3 trials of Balovaptan, Roche abandoned its work on the drug, concluding that it did not improve socialization or communication in autistic adults.12 13
If you would like to receive an e-mail notice of the most recent articles published in The Vaccine Reaction each week, click here.
Click here to view References:2 Fortune Business Insights. Autism Spectrum Disorder Treatment Market Share To Achieve Notable Growth, Driven by 8.5% CAGR. News Channel Nebraska Southeast Feb. 12, 2024.
3 Fortune Business Insights. Autism Spectrum Disorder Treatment Market Size, Share & COVID-19 Impact Analysis, By Treatment Type (Communication & Behavioral Therapies {Applied Behavior Analysis (ABA), Speech & Language Therapy, Occupational Therapy, and Others}, Drug Therapies {Antipsychotic Drugs, Selective Serotonin Reuptake Inhibitors, Stimulants, Sleep Medications, and Others}), By Type (Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder, and Others), and Regional Forecast, 2023-2030. Nov. 1, 2023.
4 Allied Market Research. Autism Spectrum Disorders Market Size, Share, Competitive Landscape and Trend Analysis Report by Disease, by Service, by Location : Global Opportunity Analysis and Industry Forecast, 2021-2031. September 2022.
5 Fortune Business Insights. Autism Spectrum Disorder Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Therapy (Antipsychotic Drugs, Selective Serotonin Reputake Inhibitors, Stimulants, Sleep Medications and Others), By Disease (Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder, and Others), By Age Group (Children and Adults), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies) and Regional Forecast, 2023-2030. Apr. 15, 2024.
6 World Population Review. Autism Rates by Country 2024.
7 TVR Staff. U.S. Autism Rate Rises to 1 in 36 Children. The Vaccine Reaction Apr. 3, 2023.
8 World Health Organization. Autism. Nov. 15, 2023.
9 WebMD. What Are the Treatments for Autism? Jan. 12, 2023.
10 raisingchildren.net.au. Medicines and autism.
11 McDougle C. Behavioral Medication Side Effects. Autism Speaks.
12 Reuters. Roche wins FDA’s breakthrough therapy label for autism drug. Jan. 29, 2018.
13 Herpen R. Balovaptan failed to improve socialization, communication in adults with autism. Healio Mar. 2, 2022.
12 Responses
September 5, 2023 Do Vaccines Cause Autism? The Evidence Against Vaccine Safety Part II of a Three-part Series By Helen Buyniski, Richard Gale, and Dr. Gary Null
It is immoral and scientifically dishonest to try to sweep under the rug a more-than-plausible connection between thimerosal in vaccines and the many neurodevelopmental injuries suffered by children during the years when they regularly received dangerously high doses as a matter of routine, and in those unborn children who are still exposed today in utero to the thimerosal-containing combination flu and Td vaccines because women have not been informed of the risks.
https://www.globalresearch.ca/do-vaccines-cause-autism-evidence-against-vaccine-safety/5830600
stop jabbing our children & watch these numbers decline!
You know it Deborah A Gray!
It’s interesting that the stats are judged concerning only eight-year-old children on the spectrum, and not the stats of much younger children who, by receiving intense treatment, recovered to the degree that they were able to attend school.
There is a great non-prescription product that helps tremendously with autism. Autistic kids have no oxytocin production, so they do not want to bond or get along with others, Adequate levels of vit D3 (levels just under 100) with increase the production of oxytocin and they will usually start interacting more at school and at home. Many providers are unaware of this because they are getting continuing medical education from the pharmaceutical industry.
Big (p) harma made billions creating this problem and now will make billions treating this problem . What is wrong with this picture??
As usual the government has created this problem and now they will provide a solution. All benefitting them of course.
Every aspect of health care and, living in general, is being set up to be taken over by corporate owned and run human capital markets aka social impact financing. No doubt management of autism is also a target. It’s set up as a P3 system of governance involving guaranteed streams of taxpayer money, the power of government enforcement to include restrictions for those who are non-compliant, along with continuous surveillance. That’s why city zoos are now requiring timed entrance reservations accessed with smartphone tracking devices. Seems innocuous but it is not. The bullet some of us thought we collectively dodged with the covid passports is still coming at us like a freight train. Stay vigilant and think about next level human management projects that are more about control than achieving good health.
until they admit the truth it will only get worse. There are effective treatments other than drugging a kid. ABA was not worth reading the book. Training repetitive behavior–makes it worse–any changes in routines makes the behaviors worse. $20,000 later; that is how much that lesson cost.. Find a good doctor that treats kids with autism and the recovery is more likely to happen. But the lies will still continue. My daughter was diagnosed in 1998. I would have thought someone would have caught on by now. My daughter is recovered; living on her own for 9 years and working as a registered nurse (put herself through school even)
That is a beautiful story! We would love to know what treatments you found for your daughter. We went with ABA for several years and found that it brought our son back to us to some extent. At least he was able to focus and make eye contact. However, he became extremely prompt-dependent. Anticonvulsants have also taken their toll over the years, but we never stop looking for ways to try to help him, even though he is well into his 30’s. We have tried to find holistic doctors but his seizures have forced us into a never-ending dependence on the very system that put him in this situation. He has surely paid a heavy price for our trust in the healthcare system that told us his DPT vaccine was “safe and effective.”
Dr. Julie Buckley in Ponte Vedra Beach FL was my daughter’s doctor. We started on the gluten and casein free diet when she was 7 years old along with some dietary supplements. Kirkman Enzyme Complete with DPPIV Isogest Pro Bio Gold and Super Nu Thera with P5P. I did this on my own. She did well on these. Started becoming alert; stopped hitting kicking and screaming. Started doing school work. Another round of ear aches another vaccine. I was told they took the toxins out of the vaccines. How stupid was I??? Then by accident I heard Dr. Bradstreet on the News in Jacksonville, FL. I called his office and found Dr. Buckley was treating children with autism. Her office number is 904-543-1288. She has a book “Healing Our Autistic Children” Ann Milan another great mom recovered her daughter when she was in her late 20’s. She was able to work and live on her own. She wrote a book “Autism –Believe in the Future” Age does not matter. Your person with autism can be any age and have a better quality of life. I will pray for you. And pray for end to all this mess.
I post an message answering yours. I usually check to see if it has gone through. So here goes again In 2002 I put my daughter on the gluten and casein free diet. No corn. Had bad reactions to corn. Along with Kirkman Enzyme Complete with DPPIV Isogest; Super Nu Thera with P5P. Pro Bio Gold and fish oil. She did well; starting to be a new kid. No more hitting; biting; kicking and screaming. Still lots of autism issues. In 2003 another round of antibiotics for ear ache and another vaccine. (I fell for the its safe; toxins are out of the vaccines) My daughter was worse the next day. I heard Dr. Bradstreet talk about the vaccines and treatments for kids with autism. I called his office and found Dr. Buckley in 2003. She is in Ponte Vedra FL office number is 904-543-1288. I will pray for your person with autism to be recovered. She wrote a book “Healing Our Autistic Children” Also Ann Milan recovered her daughter in her late 20’s. She has a book “Autism Believe in the Future”.